New Delhi, March 25 -- ChatGPT maker OpenAI on Wednesday abruptly announced that it would be shutting down its AI video generator Sora, six months after the launch of its stand-alone app for creating ... Read More
New Delhi, March 25 -- The domestic benchmark indices, Nifty 50 and Sensex, on Tuesday, March 24, participated in a global surge on Tuesday, spurred by US President Donald Trump's decision to delay st... Read More
New Delhi, March 25 -- The domestic benchmark indices, Nifty 50 and Sensex, on Tuesday, March 24, participated in a global surge on Tuesday, spurred by US President Donald Trump's decision to delay st... Read More
New Delhi, March 25 -- Royal Enfield Interceptor 650 is the flagship roadster of the OEM that comes blending 1960's British motorcycle design philosophy with modern engineering, technology and feature... Read More
New Delhi, March 25 -- In every crisis lies an opportunity, it is said. At the very least, today's hydrocarbon crisis should re-open India's forlorn debate on pushing oil and gas into a closer market ... Read More
New Delhi, March 25 -- After a record-breaking opening weekend, Dhurandhar: The Revenge closed its first Tuesday with numbers that left the trade industry stunned. Day 6 final figures are now in. Ranv... Read More
New Delhi, March 25 -- A Democrat is poised to represent President Donald Trump and his Mar-a-Lago residence in the Florida state House of Representatives after Republicans lost a special election in ... Read More
MUMBAI/NEW DELHI, March 25 -- As semaglutide, the drug behind weight-loss drug Ozempic, goes off-patent in India and cheaper copies flood the market, Novo Nordisk has moved to defend its flagship bran... Read More
New Delhi, March 25 -- The Pentagon is expected to deploy thousands of troops from the 82nd Airborne Division to the Middle East at the same time US President Donald Trump talks about "very good" talk... Read More
MUMBAI/NEW DELHI, March 25 -- As semaglutide, the drug behind weight-loss drug Ozempic, goes off-patent in India and cheaper copies flood the market, Novo Nordisk has moved to defend its flagship bran... Read More